PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-21

Date Title Company
21-Oct-2025 DKSH Cambodia Promotes Equity in Women’s Health Through Free Breast Cancer Screenings on “Patient Purpose Day 2025” DKSH Cambodia
21-Oct-2025 Syncona Limited (“Syncona” or the “Company”) Strategy update Syncona
21-Oct-2025 Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy Kelso Pharma Italy
21-Oct-2025 Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy Kelso Pharma
21-Oct-2025 GSK’s Shingrix new prefilled syringe presentation receives positive CHMP opinion GSK
21-Oct-2025 Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™ Astraveus
21-Oct-2025 ‘Smart jab’ shows promise in treating advanced head and neck cancer The Institute of Cancer Research
21-Oct-2025 4.0% Organic Revenue Growth in 9M 2025; Eurofins on Track for Solid Full Year Growth and Margin Expansion Businesswire
21-Oct-2025 NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 NuCana
21-Oct-2025 Global study challenges ‘cancer epidemic’ in young adults – with one exception The Institute of Cancer Research
21-Oct-2025 Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Sanofi
21-Oct-2025 ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors Sanofi
21-Oct-2025 Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions Lundbeck, Contera Pharma
21-Oct-2025 VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector ACCESS Newswire
21-Oct-2025 SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System SINTX Technologies
21-Oct-2025 Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program Sanofi
21-Oct-2025 ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 ProQR
21-Oct-2025 KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery KFSHRC
21-Oct-2025 NIHR establishes 14 centres to bring commercial research into primary care settings NIHR
21-Oct-2025 Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation Galapagos